SurvivorNet on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...
Zap Energy has advanced its Century fusion engineering test platform to operate for more than one hundred plasma shots at 0.2 ...
“For whatever reasons men might choose to not proactively seek care, it is important to educate these men that there are modern screening methods for prostate cancer beyond the old methods,” Nix said.
Electrical & Biomedical Engineering (EBME) Professor Xiaoshan Zhu and his colleagues have won a U.S. National Science Foundation (NSF) Phase 2 award to develop this test after proving their concept ...
We thank Lanwei Guo for their interest in the acute toxicity comparison from the PACE-C trial.1 We agree, as acknowledged in ...
The PACE-C trial reported by Alison C Tree and colleagues1 provides pivotal evidence comparing stereotactic body radiotherapy (SBRT) with moderately hypofractionated radiotherapy (MHRT) in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results